about
Modeling of antigenomic therapy of mitochondrial diseases by mitochondrially addressed RNA targeting a pathogenic point mutation in mitochondrial DNASmall interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer modelCarrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group.Cholesterol-Containing Nuclease-Resistant siRNA Accumulates in Tumors in a Carrier-free Mode and Silences MDR1 Gene.Modified siRNA effectively silence inducible immunoproteasome subunits in NSO cells.Short double-stranded RNA with immunostimulatory activity: sequence dependence.2'-O-methyl-modified anti-MDR1 fork-siRNA duplexes exhibiting high nuclease resistance and prolonged silencing activity.Selective protection of nuclease-sensitive sites in siRNA prolongs silencing effect.Exploring accessibility of structural elements of the mammalian 40S ribosomal mRNA entry channel at various steps of translation initiation.Molecular contacts of ribose-phosphate backbone of mRNA with human ribosome.Multipyrene tandem probes for point mutations detection in DNA.A central fragment of ribosomal protein S26 containing the eukaryote-specific motif YxxPKxYxK is a key component of the ribosomal binding site of mRNA region 5' of the E site codonPositioning of mRNA codons with respect to 18S rRNA at the P and E sites of human ribosome.New photoreactive oligoribonucleotide conjugates: hybridization and modification assays.[Oligo(2'-O-methylribonucleotides) and their derivatives: III. 5'-mono- and 5'-bispyrenyl derivatives of oligo(2'-O-methylribonucleotides) and their 3'-modified analogues: synthesis and properties]Structural rearrangements in mRNA upon its binding to human 80S ribosomes revealed by EPR spectroscopy.Nuclease-resistant 63-bp trimeric siRNAs simultaneously silence three different genes in tumor cells.Characterization of chemically modified oligonucleotides targeting a pathogenic mutation in human mitochondrial DNA.Targeting insulin-like growth factor I with 10-23 DNAzymes: 2'-O-methyl modifications in the catalytic core enhance mRNA cleavage.Silencing activity of 2′-O-methyl modified anti-MDR1 siRNAs with mismatches in the central part of the duplexesNovel Method for the Synthesis of 2′ -Phosphorylated OligonucleotidesProtein S3 in the human 80S ribosome adjoins mRNA 3′ of the A-site codonOligoribonucleotides with Functionalized Nucleobases as New Modifiers of BiopolymersmRNA 3' of the A site bound codon is located close to protein S3 on the human 80S ribosomeFluorophore Labeling Affects the Cellular Accumulation and Gene Silencing Activity of Cholesterol-Modified siRNAs In VitroThe human ribosome can interact with the abasic site in mRNA via a specific peptide of the uS3 protein located near the mRNA entry channelExploring the interactions of short RNAs with the human 40S ribosomal subunit near the mRNA entry site by EPR spectroscopyNovel Convenient Approach to the Solid-Phase Synthesis of Oligonucleotide ConjugatesKnockdown of the Ribosomal Protein eL29 in Mammalian Cells Leads to Significant Changes in Gene Expression at the Transcription Level
P50
Q33676663-3EC30293-7809-4EC0-9A64-BEB720588492Q34123598-28C6A8E4-7296-42B8-A541-C0D34CDBDE69Q35823611-1E9D24A9-36AC-4FD7-9A33-9C99F5B269B8Q37718210-B208C451-D878-4C44-A722-4B4D7F397DE2Q38788817-648B4D58-D722-4DDC-B5B0-44A5B40AC674Q39363405-7B4551EB-2C22-4E02-9918-BA7C022F49CFQ39638822-968D2AA7-71A8-4DB3-A130-1413879CC79BQ39864408-EAD59EED-E80A-4DD1-A786-189878F5F12EQ40680806-59A94C51-A09B-4068-AB91-3FB66C2F99E8Q40844013-642380CE-D676-4EDD-8F1C-4DF08C6887F1Q41862092-564C6333-B105-4CC8-A0AB-58B2B49ECE29Q42252266-57777921-80D9-4CE1-AAB0-AA4ABE1D1345Q44448720-35D5661E-9509-4313-BC9D-C2E562105B29Q45160166-331A51A3-1502-4D04-81A6-EA2FB0AFA32CQ46211406-D7D65793-8799-4E1A-9C19-ABD1217A0725Q47384205-814F48FD-FFE1-48F9-B967-EF5F5EFCC8C0Q49350900-4B59B820-F6A4-4912-B225-97B0FAC7B1CBQ51787657-6AF406A5-4F70-4099-951C-54145BFFDA6CQ53184248-A827EE5D-9316-47D9-9314-E55E55079BE1Q59235934-13C2E760-0A2C-41DE-8AFD-6CD4D5EB94B3Q59236010-51F062BE-A3B2-4460-9108-865019534716Q59236021-928780A6-A1C3-437C-BBF1-5A3D539B6024Q59236111-B01B807E-9E82-4AAB-8E95-C0B1E527366AQ79442406-1289B311-2997-4B13-8A3C-F91BDD83F549Q90613473-D221218E-ED98-4359-89E7-06BD8D813412Q90807129-B2FACA51-DABC-4F5F-BB0D-FC2F6BED332DQ91276995-0A442ED3-5F2A-48C9-9D86-388C368440C8Q91468049-0301A0C9-502A-4534-A679-C05354F53FA7Q95320568-39122AC5-61B0-4ACA-B74B-56FB406F632B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mariya I Meschaninova
@ast
Mariya I Meschaninova
@en
Mariya I Meschaninova
@es
Mariya I Meschaninova
@nl
Mariya I Meschaninova
@sl
type
label
Mariya I Meschaninova
@ast
Mariya I Meschaninova
@en
Mariya I Meschaninova
@es
Mariya I Meschaninova
@nl
Mariya I Meschaninova
@sl
altLabel
Mariya Meshchaninova
@en
prefLabel
Mariya I Meschaninova
@ast
Mariya I Meschaninova
@en
Mariya I Meschaninova
@es
Mariya I Meschaninova
@nl
Mariya I Meschaninova
@sl
P106
P21
P31
P496
0000-0003-0045-2413